Evidence map›Paper›PMID 24465218›Full record

ArticlePLoS genetics2014

Functional divergence and evolutionary turnover in mammalian phosphoproteomes.

Luca Freschi, Mazid Osseni, Christian R Landry

Abstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Phospho-Regulation of Meiotic Prophase.Frontiers in cell and developmental biology · 2021
    Review
  10. Article
  11. Review
  12. The evolutionary scaling of cellular traits imposed by the drift barrier.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. A Theoretical Framework for Evolutionary Cell Biology.Journal of molecular biology · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Role of AMP-activated protein kinase in metabolic depression in animals.Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Luca FreschiDépartement de Biologie, Université Laval, Québec, Canada ; Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec, Canada ; PROTEO, The Quebec Research Network on Protein Function, Structure and Engineering, Université Laval, Québec, Canada.
Mazid OsseniDépartement de Biologie, Université Laval, Québec, Canada ; Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec, Canada ; PROTEO, The Quebec Research Network on Protein Function, Structure and Engineering, Université Laval, Québec, Canada.
Christian R LandryDépartement de Biologie, Université Laval, Québec, Canada ; Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec, Canada ; PROTEO, The Quebec Research Network on Protein Function, Structure and Engineering, Université Laval, Québec, Canada.

Funding

Canadian Institutes of Health Research GMX-191597
6 · The paper itself

Abstract

Protein phosphorylation is a key mechanism to regulate protein functions. However, the contribution of this protein modification to species divergence is still largely unknown. Here, we studied the evolution of mammalian phosphoregulation by comparing the human and mouse phosphoproteomes. We found that 84% of the positions that are phosphorylated in one species or the other are conserved at the residue level. Twenty percent of these conserved sites are phosphorylated in both species. This proportion is 2.5 times more than expected by chance alone, suggesting that purifying selection is preserving phosphoregulation. However, we show that the majority of the sites that are conserved at the residue level are differentially phosphorylated between species. These sites likely result from false-negative identifications due to incomplete experimental coverage, false-positive identifications and non-functional sites. In addition, our results suggest that at least 5% of them are likely to be true differentially phosphorylated sites and may thus contribute to the divergence in phosphorylation networks between mouse and humans and this, despite residue conservation between orthologous proteins. We also showed that evolutionary turnover of phosphosites at adjacent positions (in a distance range of up to 40 amino acids) in human or mouse leads to an over estimation of the divergence in phosphoregulation between these two species. These sites tend to be phosphorylated by the same kinases, supporting the hypothesis that they are functionally redundant. Our results support the hypothesis that the evolutionary turnover of phosphorylation sites contributes to the divergence in phosphorylation profiles while preserving phosphoregulation. Overall, our study provides advanced analyses of mammalian phosphoproteomes and a framework for the study of their contribution to phenotypic evolution.

Indexed as

Evolution, MolecularAmino AcidsAnimalsBinding SitesConserved SequenceGenome, HumanHumansMicePhosphorylationProtein Processing, Post-TranslationalProteinsProteomeAmino AcidsProteinsProteome

Identifiers

PMID24465218
PMCPMC3900387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.